$134.08After hours+13.64% · 3M
Moving avg
1W-0.20%
1M+20.13%
3M+14.41%
6M-9.50%
YTD-25.32%
1Y+7.66%
3Y+493.18%
5Y+461.46%
52-week range
$90.3934% of range$212.75
Company health
Value0/6
Growth3/6
Profitability1/6
Health2/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 51% upside to a $199 target
- Analyst consensus is "Buy"
- Revenue compounding 64% a year
Risks
- Currently unprofitable
- Burning free cash flow
Key statistics
Valuation
Market cap
$28.67B
Enterprise value
$23.39B
P/E ratio (TTM)
-18.64x
P/S ratio (TTM)
28.34x
EV/EBITDA
-21.64x
Per share & returns
EPS (TTM)
-$5.49
Dividend yield
0.00%
Beta (1Y)
0.78
30-day change
+20.13%
Trading
Volume (24h)
0
Previous close
$132.57
Shares outstanding
216.75M
About Insmed Incorporated
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
INSM
Insmed Incorporated is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker INSM.
Frequently asked questions
What is Insmed Incorporated's market cap?
Insmed Incorporated (INSM) has a market capitalization of $28.67B.
What sector is Insmed Incorporated in?
Insmed Incorporated operates in the Healthcare sector, Biotechnology industry.
What exchange does INSM trade on?
INSM trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.62B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.17B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.86B cap